Pancreatic cancer(PaC)shows a clear tendency to increase in the next years and therefore represents an important health and social challenge.Currently,there is
Pancreatic cancer remains a lethal disease and is associated with poor prognosis,particularly for patients with distant metastasis at diagnosis.Recently,Oweira
Hepatocellular carcinoma(HCC)is the most common primary liver malignant neoplasia.HCC is characterized by a poor prognosis.The need to find new molecular marker
In recent years,the use of fluorescence-guided surgery(FGS)to treat benign and malignant visceral,hepatobiliary and pancreatic neoplasms has significantly incre